93 5256 93 5256
Pill imprint 93 5256 93 5256 has been identified as Clindamycin hydrochloride 300 mg.
Clindamycin is used in the treatment of bacterial infection; bacterial vaginitis; sinusitis; diverticulitis; skin infection (and more), and belongs to the drug class lincomycin derivatives. There is no proven risk in humans during pregnancy.
Clindamycin 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Clindamycin hydrochloride Images
- Imprint:
-
93 5256
93 5256 - Strength:
- 300 mg
- Color:
- Blue
- Size:
- 22.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Lincomycin derivatives
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00093-5256
Advertisement
More Clindamycin Hydrochloride resources
- Clindamycin
- Clindamycin (Wolters Kluwer)
- Clindamycin Solution (Wolters Kluwer)
- Clindamycin Suspension (Wolters Kluwer)
- clindamycin (Cerner Multum)
- Dalacin C Palmitate (Micromedex) - Includes Dosage Information
- clindamycin Oral, Injection, Intravenous (Micromedex) - Includes Dosage Information
- Clindamycin Hydrochloride (AHFS DI)
- Clindamycin Phosphate (AHFS DI)
- Clindamycin Capsules (FDA)
- Clindamycin Injection (FDA)
- Clindamycin Palmitate Hydrochloride Granules (FDA)
Clindamycin Hydrochloride is associated with the treatment of:
- Aspiration Pneumonia
- Babesiosis
- Bacteremia
- Bacterial Endocarditis Prevention
- Bacterial Infection
- Bacterial Vaginitis
- Bone infection
- Deep Neck Infection
- Diverticulitis
- Intraabdominal Infection
- Joint Infection
- Malaria
- Pelvic Inflammatory Disease
- Peritonitis
- Pneumocystis Pneumonia
- Pneumonia
- Prevention of Perinatal Group B Streptococcal Disease
- Sinusitis
- Skin Infection
- Surgical Prophylaxis
- Toxoplasmosis
- Toxoplasmosis, Prophylaxis
Search Again
